SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-255878
Filing Date
2023-10-13
Accepted
2023-10-13 11:54:30
Documents
14
Period of Report
2023-10-13
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d566894d8k.htm   iXBRL 8-K 94659
5 GRAPHIC g566894g66m01.jpg GRAPHIC 75781
6 GRAPHIC g566894g66m02.jpg GRAPHIC 78670
  Complete submission text file 0001193125-23-255878.txt   607120

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA rvmd-20231013.xsd EX-101.SCH 2887
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE rvmd-20231013_lab.xml EX-101.LAB 17236
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rvmd-20231013_pre.xml EX-101.PRE 10837
8 EXTRACTED XBRL INSTANCE DOCUMENT d566894d8k_htm.xml XML 3234
Mailing Address 700 SAGINAW DR REDWOOD CITY CA 94063
Business Address 700 SAGINAW DR REDWOOD CITY CA 94063 415-766-3638
Revolution Medicines, Inc. (Filer) CIK: 0001628171 (see all company filings)

IRS No.: 472029180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39219 | Film No.: 231324391
SIC: 2836 Biological Products, (No Diagnostic Substances)